Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health Post published:November 19, 2020 Post category:Press Release
Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program Post published:November 17, 2020 Post category:Press Release
Field Trip Health Ltd. Prepares to Enter Oregon Market following the Passage of Measure 109 in Oregon, Creating the First Legal Market for Psilocybin Services Post published:November 5, 2020 Post category:Press Release
Update on Field Trip’s Jamaica Facility – Architectural Renders Released Post published:November 4, 2020 Post category:News
Oregon and DC Decriminalisation Initiative Successes: The Psychedelics Sector Reacts Post published:November 4, 2020 Post category:Interview/News
Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development Post published:October 29, 2020 Post category:Press Release
Field Trip Health Ltd. Continues Expansion With Psychedelic-Enhanced Therapy Center in Chicago Post published:October 22, 2020 Post category:Press Release
Heroic Hearts Project and Field Trip Health Ltd. enter into a strategic relationship to increase legal psychedelic therapy access for military veterans in North America Post published:October 14, 2020 Post category:Press Release
Field Trip Adds Acclaimed Physician, Dr. Andrew Weil, to Medical Advisory Board Post published:October 8, 2020 Post category:Press Release
Field Trip Health Ltd. to Commence Trading on the CSE on October 6 Under Ticker Symbol FTRP Post published:October 5, 2020 Post category:Press Release